Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.551.571.551.401.55

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 13.55 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,487.5 Cr -2.6% 5.9% 44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.6%

5.9%

44.7%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses